ARTICLE
12 February 2024

Walking The Walk: Federal Trade Commission Lawsuit Targets Private Equity Roll-Up Strategy

SR
Schulte Roth & Zabel LLP

Contributor

With a firm focus on private capital, Schulte Roth & Zabel comprises legal advisers and commercial problem-solvers who combine exceptional experience, industry insight, integrated intelligence and commercial creativity to help clients raise and invest assets and protect and expand their businesses.
In an article for The Journal of Federal Agency Action titled, "Walking the Walk: Federal Trade Commission Lawsuit Targets Private Equity Roll-Up Strategy," Schule Roth & Zabel partner Peter Jonathan...
United States Corporate/Commercial Law
To print this article, all you need is to be registered or login on Mondaq.com.

In an article for The Journal of Federal Agency Action titled, "Walking the Walk: Federal Trade Commission Lawsuit Targets Private Equity Roll-Up Strategy," Schule Roth & Zabel partner Peter Jonathan Halasz and special counsel Ngoc Pham Hulbig discuss the Federal Trade Commission's (FTC)lawsuit against US Anesthesia Partners (USAP) and its private equity backer.

The FTC has sued USAP and its private equity backer, Welsh, Carson, Anderson & Stowe LP (Welsh Carson), alleging that USAP and Welsh Carson violated antitrust law through a three-pronged scheme to monopolize the anesthesiology market in Texas to drive up prices and increase profits.

To view the full article please click here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More